| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/20/2007 | EP1797070A1 Compounds, compositions containing them, preparations thereof and uses thereof ii |
| 06/20/2007 | EP1797051A1 Benzoxazine and quinoxaline derivatives and uses |
| 06/20/2007 | EP1797036A1 Sigma receptor ligands |
| 06/20/2007 | EP1796793A2 Novel compounds |
| 06/20/2007 | EP1796678A2 Carboxamide spirolactam cgrp receptor antagonists |
| 06/20/2007 | EP1796663A2 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 06/20/2007 | EP1796658A2 Dopaminergic mimetics |
| 06/20/2007 | EP1796657A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/20/2007 | EP1796635A2 D-methionine formulation with improved biopharmaceutical properties |
| 06/20/2007 | EP1611094B1 Pyrazole compounds |
| 06/20/2007 | EP1610786B1 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 06/20/2007 | EP1455770B1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
| 06/20/2007 | EP1414457B1 Chiral dinapsoline |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP1324760B1 Creatine ester pronutrient compounds and formulations |
| 06/20/2007 | EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/20/2007 | EP1272204B1 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 06/20/2007 | CN1985169A Use of TWEAK modulators and inhibitors for the treatment of neurological conditions |
| 06/20/2007 | CN1984914A Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as protein kinase ingibitor |
| 06/20/2007 | CN1984911A 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha7-NACHR ligands for the treatment of CNS diseases |
| 06/20/2007 | CN1984910A Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 06/20/2007 | CN1984907A Novel heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/20/2007 | CN1984906A Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 06/20/2007 | CN1984905A Constrained himbacine analogs as thrombin receptor antagonists |
| 06/20/2007 | CN1984888A Substituted azetidine compounds, their preparation and use as medicaments |
| 06/20/2007 | CN1984883A Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 06/20/2007 | CN1984681A Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| 06/20/2007 | CN1984670A Cyclosporins to treat alzheimer's disease |
| 06/20/2007 | CN1984659A Opioids for the treatment of the restlessness of the lower limbs |
| 06/20/2007 | CN1984646A Use of phenylethanolaminotetralines for preparing anxiolytic drugs |
| 06/20/2007 | CN1984645A Memantine as adjunctive treatment to atypical antipsychotic in schizophrenia patients |
| 06/20/2007 | CN1982457A Toxic sequential, its preparation and use |
| 06/20/2007 | CN1982455A Polynucleotide for inhibiting Wnt activity, its encoded polypeptide and use |
| 06/20/2007 | CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/20/2007 | CN1982310A Production of high-purity corydalis |
| 06/20/2007 | CN1981873A Method of manufacturing micro colloidal particle and use of the same |
| 06/20/2007 | CN1981857A Medicinal composition of milkvetch root, chinaroot greenbrier and Hong Jingtian and its making method |
| 06/20/2007 | CN1981852A Tall gastrodia tuber preparation with resuscitation-inducing function, its making and quality controlling method |
| 06/20/2007 | CN1981802A Chinese-medicinal preparation for treating cardiovascular diseases, its production and use |
| 06/20/2007 | CN1981780A Strontium compound for treatment of sub-dermal soft tissue pain |
| 06/20/2007 | CN1981776A Composition containing rare ginseng saponin, its production and usage |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1981752A Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine |
| 06/20/2007 | CN1981746A Fluoxetine hydrochloride oral disintegrant tablets and their production |
| 06/20/2007 | CN1981744A Production of injection slow-releasing micropills of lycopodine and its derivative |
| 06/20/2007 | CN1981742A Solid pharmaceutical dispersions with enhanced bioavailability |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/20/2007 | CN1321666C Combination of medication of containing astragalus root and dragon's blood resin and application |
| 06/20/2007 | CN1321654C Drink of Chinese angelica and read-rooted salvia root |
| 06/20/2007 | CN1321644C Process for making substituted pyrazoles |
| 06/20/2007 | CN1321643C Naloxone hydrochloride powder injection and its preparing method |
| 06/20/2007 | CN1321640C Application of benzydalysine in preparing medicine for treating diabetic peripheral neuropathy |
| 06/20/2007 | CN1321635C Binding partners for 5-HT5 receptors for treatment of migraine |
| 06/20/2007 | CN1321634C Use of 6-dimethylaminomethy1-1-pheny1-cyclohexane compounds for treating urinary incontinence |
| 06/20/2007 | CA2530904A1 Pharmaceutical agents for the treatment of pain associated with spinal cord injury |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232846 endogenic polyamines (putrescine, spermidine, spermine), 1,3-propanediamine, their salts and solvates, bioprecursor amides for therapeutical and prophylactic treatment of alcoholism in a human |
| 06/19/2007 | US7232830 Administering to a patient a compound for increasing neuronal metabolism of histamine to a histamine H2 agonist, to stimulate production of adenosine 3*,5*- cyclic phosphate at a level which maintains myelin against self degeneration |
| 06/19/2007 | US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 06/19/2007 | US7232823 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | US7232814 Heterocyclic carboxy amines such as 9-nitro-7,12-dihydroindolo (3,2-d)(1)-benzazepin-6(5H)-one, used as inhibitors of glycogen synthase kinase-3 beta or cyclin dependent kinases |
| 06/19/2007 | US7232813 Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders |
| 06/19/2007 | US7232575 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 06/19/2007 | CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 06/19/2007 | CA2182939C A rapidly disintegrating medicinal form of tramadol or a tramadol salt |
| 06/19/2007 | CA2066738C Prevention, treatment and amelioration of a pathology characterized by brain inflammation |
| 06/15/2007 | CA2530345A1 Composition and method for mitigating a negative effect of alcohol consumption |
| 06/14/2007 | WO2007067581A1 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride |
| 06/14/2007 | WO2007067489A1 Quinolone m1 receptor positive allosteric modulators |
| 06/14/2007 | WO2007066928A1 Use of the extract of caesalpinia sappan l. and compounds therefrom |
| 06/14/2007 | WO2007066068A2 Calcium ion channel receptor antagonist |
| 06/14/2007 | WO2007065892A1 Novel diazabicyclic aryl derivatives and their medical use |
| 06/14/2007 | WO2007065820A1 Tricyclic amide derivatives useful for treating obesity |
| 06/14/2007 | WO2007065714A1 A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof |
| 06/14/2007 | WO2007065713A2 Use of 8-alpha-ergolines for the treatment of traumatic brain disorders |
| 06/14/2007 | WO2007065663A1 Quinazolinone derivatives as vanilloid antagonists |
| 06/14/2007 | WO2007065655A1 Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission |
| 06/14/2007 | WO2007065619A2 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 06/14/2007 | WO2007065595A2 Xanthine derivatives, processes for preparing them and their uses |
| 06/14/2007 | WO2007065449A1 Pyrimidine derivatives and their use as kcnq potassium channels openers |
| 06/14/2007 | WO2007065448A1 Stable solid formulation of sertindole |
| 06/14/2007 | WO2007050721A3 Heterocyclic aspartyl protease inhibitors |
| 06/14/2007 | WO2007047401A3 A1 adenosine receptor agonists |
| 06/14/2007 | WO2007044560A3 Modulators of atp-binding cassette transporters |
| 06/14/2007 | WO2007042035A3 Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| 06/14/2007 | WO2007041418A3 Methods and compositions for improving cognitive function |
| 06/14/2007 | WO2007004685A3 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 06/14/2007 | WO2006099379A3 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 06/14/2007 | US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135496 Substituted benzylaminoalkylene heterocycles |
| 06/14/2007 | US20070135484 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 06/14/2007 | US20070135458 6-Substituted pyrido-pyrimidines |